CVS Health Corp. continues to deploy capital to execute on its vision of becoming a leading health company, including its announced acquisition of Signify Health this year. Separately, CVS announced last month it has agreed to pay about $5 billion over the next 10 years beginning in 2023 to substantially resolve all opioid lawsuits by states, political subdivisions and tribal entities. We revised our outlook to stable from positive and affirmed all our ratings on CVS, including our 'BBB' issuer credit rating and issue-level ratings. The stable outlook reflects that with recent earnings and financial policy guidance, we now expect leverage to remain above 3x on an S&P Global Ratings-lease-adjusted basis in the coming one to two years. We note
